Abstract
Abstract
Background
Reprocessed devices must be thoroughly cleaned prior to sterilization to ensure efficacy of sterilization agents. Many single-use devices are not designed to be thoroughly cleaned. Interlocking design features inherent to LigaSure™ vessel sealing devices may prevent thorough cleaning and promote accumulation of human tissue that cannot be removed. Thus, the aim of this study was to compare industry reprocessed and new LigaSure™ vessel sealing devices for organic material.
Methods
A total of 168, 84 new and 84 reprocessed, vessel sealing devices were disassembled and inspected for the presence of residual organic matter using visual, microscopic, and chemical analysis. Devices were randomized and test conductors blinded to group membership. Devices were aseptically disassembled and sent through visual inspection. Next, devices were either examined using light microscopy, scanning electron microscopy (SEM) or exposed to a solution that luminesces in the presence of hemoglobin. Additionally, 165 reprocessed devices were sent to a 3rd party lab for sterility testing via direct immersion culture for 14 days.
Results
Significant amounts of remnant organic material (C, N, O, S, Na, P) were observed with 81/84 reprocessed and 0/84 new devices failing inspection protocols. When tested for the presence of hemoglobin, only 1/12 reprocessed devices passed inspection. SEM of reprocessed devices revealed residues with liquid patterns and diffuse soiling with foreign material. Sterility testing of reprocessed devices revealed a sterility level < 6–3.
Conclusions
The abundance of material resembling human tissue observed on reprocessed VSDs suggests inadequate cleaning prior to sterilization. Atomic and morphological analyses of the remnant materials suggest that bacterial biofilms could also be present. Additionally, surface degradation and release of reinforcing glass fibers from the device were observed. Devices designed for single use can harbor significant amounts of remnant material that likely interfere with the sterilization process.
Funder
Medtronic
University of Colorado Denver|Anschutz Medical Campus, Department of Bioengineering
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Haque M, Sartelli M, McKimm J, Bakar MA (2018) Health care-associated infections–an overview. Infect Drug Resist 11:2321
2. Health Care-Associated Infections. Agency for Healthcare Research and Quality, Rockville, MD
3. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, Keohane C, Denham CR, Bates DW (2013) Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 173:2039–2046
4. Mansur J, JCI. Reuse of Single-Use Devices: Understanding Risks and Strategies for Decision-Making for Health Care Organizations (2017) Available at: https://www.jointcommissioninternational.org/-/media/feature/news/jci_white_paper_reuse_of_single_use_devices2pdf.pdf?db=web&hash=6A41E61718E881E936AF4289BE36DA82. Accessed 17 Mar 2020
5. US Food and Drug Administration, Medical device user fee and modernization act. H.R. 3580, 107th Cong (2000) Availible at: https://www.fda.gov/industry/medical-device-user-fee-amendments-mdufa/medical-device-user-fee-and-modernization-act-2002-mdufma-pl-107-250. Accessed 5 May 2020
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献